India speaks often about ending tuberculosis. Campaigns, targets, dashboards, and declarations dominate the national narrative. Yet within this broad TB discourse, drug-resistant TB (DR-TB), one of the deadliest forms of the disease, remains a neglected public health emergency. The Global Tuberculosis Report, 2025 of the World Health Organization shows progress: a 21% decrease in TB incidence in India, and an improvement from 53% to 92% in treatment coverage.